Organizing Committee Members

Antonio Ruggiero

Catholic University, Italy

Prof. Ruggiero received his medical degree from the Catholic University in Rome in 1992. He holds Board of Pediatrics in 1996 and Board of Pediatric Haematology and Oncology in 1998 at the Catholic University of Rome. Prof. Ruggiero is currently an associate professor in the Department of Pediatrics at the Catholic University of Rome where he is responsible for teaching Pediatrics and Pediatric Hematology and Oncology. Carrying a regular patient load as consultant in pediatric oncology allows him to maintain his clinical skills and to promote improvements in safety and quality of healthcare. Examples of activities include producing guidelines for prevention of healthcare associated treatments and improvements in basic safe medical practices. His research interests focus on pediatric clinical trials, clinical pharmacology of antineoplastic drugs, pain therapy and pediatric drugs.

Professor Mehmet Emre Atabek

Necmettin Erbakan University, Turkey

Professor Mehmet Emre Atabek has completed his Ph.D. at the age of 37 years from Erciyes University and postdoctoral studies from Selcuk University School of Meram Medicine. He is the director of Pediatric Endocrinology, a premier pediatric endocrinolgy and diabetology service organization. He has published more than 140 papers in reputed journals and has been serving as an editorial board member of repute. He has been interested in searching metabolic problems of obese children in most of his articles. His articles have been cited more than 1500 citations by another article in Web of Science so far. He continues to work as head of the Department of Pedaitric Endocrinolgy, Necmettin Erbakan University.

Waldo Concepcion

Stanford University, USA

In my early publications in my professional career, I focused on liver transplantation because this was a great focus in my training and career development. I published with my team in outcomes and new techniques in liver transplantation that were important improvements in patients undergoing liver transplants, children as well as adult patients. In the last 12 years of my career, I have re-focused my professional focus in the field of pediatric kidney transplantation. At my arrival to Stanford University, I became Chief to Pediatric Kidney Transplantation and have dedicated my research and innovation to improve the outcomes in children with complex urological and vascular disorders undergoing kidney transplantation. With the support of a dedicated team of experts, we have provided solutions for these disorders and published these results to enhance the field. The same can be said about our work in immunosuppression in children. For many years, steroids were the cornerstone of immunosuppression in transplantation. Through our innovation and multicenter trials, we brought to the field the concept that steroid-free immunosuppression was feasible and safe in children undergoing kidney transplant in selected patients without adverse outcomes to compromise graft survival. In the latest part of my career, my contribution to science is the development of new strategies to diagnose and treat children suffering of viral infections in the post-operative course. We have done extensive research in the field of BK infection and sequencing the virus to understand better new strategies for treatment. We are also developing the new generation of therapies based in Cytotoxic T-cells derived therapies for the treatment of viral infections.